Breakthrough research explains how the brain regulates scratching behaviour

Scientists have uncovered a key biological mechanism that explains how the brain normally knows when to stop scratching an itch, findings that could reshape treatment approaches for chronic skin conditions such as eczema and psoriasis.

The study, conducted by researchers at the University of Louvain in Belgium, identifies a protein called TRPV4, an ion channel found in sensory nerve fibres, as a crucial part of the body’s itch-regulation system.

According to the researchers, TRPV4 acts like a biological feedback switch. When a person scratches an itch, it sends signals through the spinal cord to the brain, indicating that the sensation has been “addressed,” helping the body naturally stop scratching.

Lead researcher Roberta Gualdani explained that this feedback loop is essential for normal itch control. 

“When we scratch an itch, at some point we stop because there's a negative feedback signal that tells us we're satisfied,” she said. 

“Without TRPV4, the mice don't feel this feedback, so they continue scratching much longer than normal.”

To study the mechanism, the team engineered genetically modified mice in which TRPV4 was selectively disabled in sensory neurons. 

These mice developed symptoms resembling chronic itch conditions such as atopic dermatitis, allowing researchers to observe how the absence of the protein affected behaviour.

While the modified mice scratched less frequently overall, each scratching episode lasted significantly longer, suggesting that TRPV4 does not simply trigger itch sensations but also plays a key role in signalling when scratching should stop.

Researchers also found that TRPV4 appears to have a dual function: when active in skin cells, it can contribute to the sensation of itch, while in neurons, it helps regulate the stopping mechanism that limits scratching behaviour.

Gualdani noted that this complexity may be important for future treatments. “Broadly blocking TRPV4 may not be the solution,” she said. 

“Future therapies may need to be much more targeted, perhaps acting only in the skin without interfering with the neuronal mechanisms that tell us when to stop scratching.”

Chronic itch affects millions of people worldwide, yet effective treatment options remain limited. 

The discovery offers new insight into why some patients experience uncontrollable scratching cycles and points toward more precise therapies that could better manage the condition in the future.